As a consequence, persistent activation of STAT3 mediates both the propagation of tumor-promoting inflammation and the suppression of anti-tumor immunity, thus forming a promising target to improve cancer therapy by modulating immune responses[16]. The gene discussed is STAT3; the disease is cancer.